Literature DB >> 15130996

Turning a blind eye: authors have blinkered view of blinding.

Stephen J Senn.   

Abstract

Mesh：

Year:  2004        PMID： 15130996      PMCID： PMC406364          DOI： 10.1136/bmj.328.7448.1135-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

Review 1.  Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.

Authors:  Dean Fergusson; Kathleen Cranley Glass; Duff Waring; Stan Shapiro
Journal:  BMJ       Date:  2004-01-22
  1 in total
  4 in total

1.  Use of dose modification schedules is effective for blinding trials of warfarin: evidence from the WASID study.

Authors:  Vicki Hertzberg; Marc Chimowitz; Michael Lynn; Cristen Chester; William Asbury; George Cotsonis
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

Review 2.  Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.

Authors:  Isabelle Boutron; Lydia Guittet; Candice Estellat; David Moher; Asbjørn Hróbjartsson; Philippe Ravaud
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

3.  Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach.

Authors:  Stephen Wright; Paul Duncombe; Douglas G Altman
Journal:  Trials       Date:  2012-10-09       Impact factor: 2.279

4.  Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT.

Authors:  Jennifer S Gewandter; James C Eisenach; Robert A Gross; Mark P Jensen; Francis J Keefe; David A Lee; Dennis C Turk
Journal:  Pain Rep       Date:  2017-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.